Brain scan study tests new Weight-Loss Drug's effect on cravings
NCT ID NCT06267092
Summary
This study tested how a new weight-loss medicine called CagriSema affects people's appetite, food cravings, and brain activity. It involved 164 adults with overweight or obesity, comparing those who received the medicine to those who received a dummy treatment. Researchers used questionnaires, food intake measurements, and brain scans to understand how the medicine works to control appetite.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité - Campus Charité Mitte - Charité Research Organisation GmbH
Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.